Comments
The stock of Ajanta Pharma will attract buyers after it announced the launch of the generic version of Singulair granules, used in the treatment of asthma, in the US. Ajanta Pharma US Inc has launched montelucast sodium granules, a generic version of Merck & Co, Inc’s Singulair granules, in the US market. Ajanta has so far received five abbreviated new drug application approvals from the US Food and Drug Administration.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.